Clinical Research Directory
Browse clinical research sites, groups, and studies.
Proton Therapy in Reducing Toxicity in Anal Cancer
Sponsor: Jordan Kharofa
Summary
The purpose of this research study is to determine whether the amount of radiation given to the normal areas around the anal cancer can be reduced by using Proton Therapy while reducing the side effects that are seen with standard therapy.
Official title: A Prospective Pilot Study to Evaluate the Feasibility of Intensity Modulated Proton Therapy in Reducing Toxicity in Anal Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2017-01-04
Completion Date
2025-07-01
Last Updated
2024-09-19
Healthy Volunteers
No
Conditions
Interventions
Proton therapy
Primary target volume 50.4-54 CGE in 28-30 fractions; Nodal volumes 42-54 CGE in 28-30 fractions
Chemotherapy
5FU 1000 mg/m2/day as 96 hour infusion days 1-5 and 29-33; Mitomycin 10mg/m2 days 1 and 29
Locations (1)
UC Health
Cincinnati, Ohio, United States